[1] van Es,
M.
A.,
Hardiman,
O.,
Chio,
A.,
Al-Chalabi,
A.,
Pasterkamp,
R.
J.,
Veldink,
J.
H.,
& van den Berg,
L.
H.
(2017). Amyotrophic lateral sclerosis. The Lancet.
[2] Brown,
R.
H.,
& Al-Chalabi,
A.
(2017).
Amyotrophic lateral sclerosis. New England Journal of Medicine, 377(2),
162-172.
[3] Turner,
M.
R.,
& Verstraete,
E.
(2015).
What does imaging reveal about the pathology of amyotrophic lateral sclerosis?. Current neurology and neuroscience reports, 15(7),
45.
[4] Fabes,
J.,
Matthews,
L.,
Filippini,
N.,
Talbot,
K.,
Jenkinson,
M.,
& Turner,
M.
R.
(2017). Quantitative FLAIR MRI in Amyotrophic Lateral Sclerosis. Academic Radiology.
[5] Bede,
P.,
Iyer,
P.
M.,
Schuster,
C.,
Elamin,
M.,
Mclaughlin,
R.
L.,
Kenna,
K.,
& Hardiman,
O.
(2016).
The selective anatomical vulnerability of ALS:‘disease-defining’and ‘disease-defying’brain regions. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 17(7-8),
561-570.
[6] Christidi,
F.,
Karavasilis,
E.,
Riederer,
F.,
Zalonis,
I.,
Ferentinos,
P.,
Velonakis,
G.,
...
& Zambelis,
T.
(2017).
Gray matter and white matter changes in non-demented amyotrophic lateral sclerosis patients with or without cognitive impairment: A combined voxel-based morphometry and tract-based spatial statistics whole-brain analysis. Brain Imaging and Behavior,
1-17.
[7] Rocha,
A.
J.
D.,
Júnior,
M.,
& Martins,
A.
C.
(2012).
Is magnetic resonance imaging a plausible biomarker for upper motor neuron degeneration in amyotrophic lateral sclerosis/primary lateral sclerosis or merely a useful paraclinical tool to exclude mimic syndromes? A critical review of imaging applicability in clinical routine. Arquivos de neuro-psiquiatria, 70(7),
532-539.
[8] Bede,
P.,
& Hardiman,
O.
(2014).
Lessons of ALS imaging: pitfalls and future directions—a critical review. NeuroImage: Clinical, 4,
436-443.
[9] Agosta,
F.,
Chio,
A.,
Cosottini,
M.,
De Stefano,
N.,
Falini,
A.,
Mascalchi,
M.,
...
& Filippi,
M.
(2010).
The present and the future of neuroimaging in amyotrophic lateral sclerosis. American Journal of Neuroradiology, 31(10),
1769-1777.
[10] Foerster,
B.
R.,
Welsh,
R.
C.,
& Feldman,
E.
L.
(2013).
25 years of neuroimaging in amyotrophic lateral sclerosis. Nature Reviews Neurology, 9(9),
513-524.